SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ladyPI who wrote (48103)12/12/2018 4:35:09 PM
From: allatwwk  Read Replies (1) of 63289
 
In a strange way, the "leak" might be a good thing. For a while now, I've wondered if there is negative info floating out there which the market knows and us retail investors don't.

I think its likely the FDA form contains exactly that news. Now we know *roughly* what IMMU's challenges are to get AA. My take, there is no "impossible obstacle" that undermines AA.

My gut (and knowledge of some of the sorts of things mentioned) says the things on the FDA form are solvable, but perhaps not as quick/trivial as we'd like. Adding a drain sounds trivial, but it can depend on permits, potential of hazardous materials entering the drain, etc. Its straightforward to do, but potentially not as quick/trivial as some might think. Example, it could be in a sensitive area and require the shutdown of operations for a period of time.

If the issues on the form were the negative info responsible for the share price's weakness over the past few months, I'm relieved. Its hard to imagine AA won't happen because of anything on the FDA form. Whether AA happens in January is less certain. I'd guess no more than a 2-4 month delay, worst case.

Bottom line -- solve the issues and get the drug on the market where it can start helping the patients who urgently need it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News